610 results on '"Baglin, T"'
Search Results
2. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data
3. Combined MR direct thrombus imaging and non-contrast magnetic resonance venography reveal the evolution of deep vein thrombosis: a feasibility study
4. Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain
5. The role of the laboratory in treatment with new oral anticoagulants
6. Variation in Structure and Process of Care in Traumatic Brain Injury: Provider Profiles of European Neurotrauma Centers Participating in the CENTER-TBI Study
7. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
8. Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH
9. Single tertiary centre experience of treating thrombotic thrombocytopenic purpura between 2010–2015: 99
10. Discovery and characterization of an antibody directed against exosite I of thrombin
11. Haemostatic response to factor VIII administration in patients with haemophilia A measured by thrombin generation and correlation with factor concentrate use
12. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study: reply
13. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
14. Reporting prothrombin time results as international normalized ratios for patients with chronic liver disease
15. Unraveling the thrombophilia paradox: from hypercoagulability to the prothrombotic state
16. Standardisation of thrombin generation test - which reference plasma for TGT?: An international multicentre study
17. Identification of new genetic risk factors for venous thrombosis by targeted sequencing: results of the MILES study: OR394
18. Identification of new genetic risk factors for recurrent venous thrombosis: OR148
19. Sex difference in the risk of venous thrombosis: a detailed analysis in four European cohorts: OR135
20. What happens after venous thromboembolism?
21. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin‐generating potential in a prospective cohort study
22. Unprovoked recurrent venous thrombosis: prediction by D‐dimer and clinical risk factors
23. Unprovoked deep vein thrombosis should be treated with long‐term anticoagulation – no
24. Prolonged clot lysis time as a potential risk factor for recurrent venous thrombosis; results from THE-VTE follow-up study: PB 3.73–2
25. External validation and updating of the Vienna Prediction Model for recurrent venous thromboembolism using a pooled individual patient data database: PB 3.70–3
26. The incidence of recurrent venous thrombosis associated with different clinical risk profiles: PB 2.71–2
27. Prediction of risk of venous thrombosis after cast immobilization of the lower extremity: PA 3.19–1
28. A new type of hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537*): OC 62.5
29. Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis
30. Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis
31. Value of D‐dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet
32. Cryoprecipitate: an outmoded treatment?
33. The potential role of synovial thrombomodulin in the pathophysiology of joint bleeds in haemophilia
34. Prevention of post-thrombotic syndrome: a case for new oral anticoagulant drugs or for heparins?
35. Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A
36. Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery
37. Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A
38. Hemodynamic consequences of pulmonary embolism: reply to a rebuttal
39. Incidental pulmonary emboli in lymphoma patients are associated with aggressive disease and poor prognosis
40. Fifty per cent of patients with pulmonary embolism can be treated as outpatients
41. Implementation of British Committee for Standards in Haematology (BCSH) Guidelines: Data from two UK NEQAS (Blood Coagulation) questionnaires: 29
42. D-dimer to predict thrombosis recurrence after unprovoked venous thromboembolism: effect of patient- and D-dimer-related factors on recurrence prediction: OC-TH-002
43. Clinical prediction guide to predict thrombosis recurrence after a first unprovoked venous thromboembolism: OC-TH-004
44. Does patient sex and prior hormonal therapy predict risk for thrombosis recurrence after a first venous thromboembolism?: AS-TH-005
45. Managing anticoagulated atrial fibrillation patients undergoing endoscopy
46. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
47. Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis
48. The endogenous thrombin potential has high positive predictive value for recurrent unprovoked venous thrombosis in the second Cambridge prospective cohort study: 175
49. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence
50. The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.